Global Patent Foramen Ovale Closure Device Market Growth 2024-2030

Global Patent Foramen Ovale Closure Device Market Growth 2024-2030

Product Code:1226255

Published Date: Sep 19,2024

Pages: 101

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

A Patent Foramen Ovale (PFO) closure device is a medical device used to treat a patent foramen ovale, a congenital heart defect where a small opening between the upper chambers of the heart (the atria) fails to close after birth. This device is typically implanted through a minimally invasive catheter procedure to seal the opening, preventing abnormal blood flow between the atria. By closing the PFO, the device reduces the risk of complications such as stroke or migraines. It is usually made of a metal framework covered with biocompatible materials, ensuring safety and effectiveness in restoring normal circulation.

The global Patent Foramen Ovale Closure Device market size is projected to grow from US$ 146 million in 2024 to US$ 199 million in 2030; it is expected to grow at a CAGR of 5.3% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Patent Foramen Ovale Closure Device Industry Forecast” looks at past sales and reviews total world Patent Foramen Ovale Closure Device sales in 2023, providing a comprehensive analysis by region and market sector of projected Patent Foramen Ovale Closure Device sales for 2024 through 2030. With Patent Foramen Ovale Closure Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Patent Foramen Ovale Closure Device industry.

This Insight Report provides a comprehensive analysis of the global Patent Foramen Ovale Closure Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Patent Foramen Ovale Closure Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Patent Foramen Ovale Closure Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Patent Foramen Ovale Closure Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Patent Foramen Ovale Closure Device.

The key drivers of the Patent Foramen Ovale (PFO) closure device market is the rising prevalence of stroke and related cardiovascular conditions. Since a PFO increases the risk of stroke, particularly cryptogenic stroke, there is growing demand for minimally invasive treatments to address this condition. Technological advancements in medical devices and increased awareness of PFO-related risks have led to a higher adoption rate of closure devices. Additionally, the growing aging population, which is more susceptible to heart-related disorders, further fuels the demand for PFO closure procedures.

Despite the increasing demand, the PFO closure device market faces significant challenges, primarily the high cost of devices and procedures. This can limit accessibility, particularly in developing regions where healthcare infrastructure and insurance coverage may be lacking. Another challenge is the risk of complications or adverse events associated with PFO closure procedures, such as device embolization or atrial fibrillation. Concerns over long-term safety and the need for more extensive clinical studies may hinder wider acceptance and regulatory approvals in certain markets.Abbott is the market leader with a market share of 80%
This report presents a comprehensive overview, market shares, and growth opportunities of Patent Foramen Ovale Closure Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Non-degradable
    Degradable

Segmentation by Application:
    Hospital
    Clinics

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Abbott
    Occlutech
    Starway
    W. L. Gore & Associates
    Lepu Medical
    LifeTech

Key Questions Addressed in this Report
What is the 10-year outlook for the global Patent Foramen Ovale Closure Device market?
What factors are driving Patent Foramen Ovale Closure Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Patent Foramen Ovale Closure Device market opportunities vary by end market size?
How does Patent Foramen Ovale Closure Device break out by Type, by Application?